Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Update on SIBIA's candidate for Alzheimer's diseases

July 28, 1997

Update on status of Cortex's Ampakine compound

July 28, 1997

Neuropeptide Y: a new target in anxiety therapy

July 28, 1997

U.K. university researchers develop new agents for AD

July 25, 1997

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

July 24, 1997

Naratriptan approved in 10 additional European countries

July 23, 1997

Schering AG describes AMPA antagonists

July 23, 1997

Toray/Daiichi codevelop analgesic

July 22, 1997

Maternal infection associated with increased risk for cerebral palsy in term infants

July 22, 1997

CoCensys to copromote Zarontin for pediatric epilepsy

July 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...